Meghan McGarry, MD, MS
Associate Professor
Pediatrics
School of Medicine
Dr. McGarry is a Pediatric Pulmonologist who researches cystic fibrosis. Her main focus is researching health disparities in cystic fibrosis, particularly in minorities. She is conducting a cohort study of lung function in Latinos/Hispanics with cystic fibrosis. She also does research in diversity in clinical trials in cystic fibrosis.
Show full bio (70 words) Hide full bio
Dr. McGarry studied Biology at Whitworth College. She then attended University of Washington School of Medicine, working in many underserved regions from Alaska to Zambia. She completed her Pediatric residency at Rainbow Babies and Children's Hospital. She completed her Pediatric Pulmonary and Pediatric Clinical Pharmacology Fellowships at University of California San Francisco. She also completed her Masters in Clinical Research at University of California San Francisco.
Awards
Show all (12) Hide
- K Boost Award, Cystic Fibrosis Foundation, 2020-2023
- K23 Career Development Award, NHLBI, 2018-2023
- Jane Addams Social Justice Award, UCSF, 2017
- Harry Schwachman Cystic Fibrosis Clinical Scholar, Cystic Fibrosis Foundation, 2016-2019
- ATS International Conference Pediatric Abstract Scholarship, American Thoracic Society, 2016
- Walter Travel Grant, Breathe California, 2015
- Best Research, Fellows Poster Presentation, California Thoracic Society, 2015
- ATS International Conference Pediatric Abstract Scholarship, American Thoracic Society, 2014
- Fellow’s Scholarship, California CF Consortium, 2014
- Pediatric Clinical Pharmacology, Drug Action, and Pharmacogenetics T32, NICHD/NIGMS, 2013-2016
- Fellow’s Scholarship, California CF Consortium, 2013
- Resident Teacher of the Year, Rainbow Babies and Children’s Hospital, 2010
Education & Training
Show all (5) Hide
- Masters Clinical Research University of California San Francisco 2015
- Pediatric Pulmonology University of California San Francisco 2015
- Pediatric Residency Rainbow Babies and Children's Hospital 2012
- M.D. University of Washington 2009
- BS Biology Whitworth College 2005
Interests
Show all (15) Hide
- Lung Function
- Clinical Pharmacology
- Diversity In Research
- Minority Inclusion In Clinical Trials
- Cystic Fibrosis Transmembrane Conductance Regulator
- Health Equality
- Pulmonary Function
- Cystic Fibrosis
- Pediatric Lung Diseases
- Health Disparities
- N of 1 Study
- Asthma
- Hispanic Latino Health
- Personalized Medicine
- Cystic Fibrosis Related Diabetes
Websites
Show all (3) Hide
- @@DrMeghanMcGarry on Twitter (twitter.com)
- Center for Latinos With Cystic Fibrosi (latinoswithcysticfibrosis.org)
- Dr. McGarry's Clinical Page (ucsfbenioffchildrens.org)
Grants and Projects
Show all (4) Hide
- Clinical Pharmacology, Drug Action and Pharmacogenetics, NIH, 1977-2025
- Risk Factors For Worse Lung Function In Latinos With Cystic Fibrosis, NIH, 2018-2023
- Risk Factors For Worse Lung Function In Latinos With Cystic Fibrosis, Cystic Fibrosis Foundation, 2016-2019
- Ivacaftor in non-G551D cystic fibrosis patients, Cystic Fibrosis Foundation, Research Development Program Grant, 2013-2015
Publications (29)
Top publication keywords:
ChloridesQuinolonesBronchodilator AgentsCystic FibrosisAsthmaSweatPseudomonas InfectionsCystic Fibrosis Transmembrane Conductance RegulatorNeonatal ScreeningAminophenolsBenzodioxolesStaphylococcal InfectionsMethicillin-Resistant Staphylococcus aureusChloride Channel AgonistsMutation
-
Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype.
Pediatric pulmonology 2021 McGarry ME, McColley SA -
Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis.
Pediatric pulmonology 2017 McGarry ME, Neuhaus JM, Nielson DW, Burchard E, Ly NP -
In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies.
Pediatric pulmonology 2017 McGarry ME, Illek B, Ly NP, Zlock L, Olshansky S, Moreno C, Finkbeiner WE, Nielson DW -
Cystic Fibrosis Foundation Evidence-Based Guideline for the Management of CRMS/CFSPID.
Pediatrics 2024 Green DM, Lahiri T, Raraigh KS, Ruiz F, Spano J, Antos N, Bonitz L, Christon L, Gregoire-Bottex M, Hale JE, Langfelder-Schwind E, La Parra Perez Á, Maguiness K, Massie J, McElroy-Barker E, McGarry ME,… -
Time to be blunt: Substance use in cystic fibrosis.
Pediatric pulmonology 2024 Vaziri S, McGarry ME, Huang CY, Cuneo AA, Willen SM, Iwanaga K, Neemuchwala F, Gibb ER, Chan M, Ly NP
Show all (24 more) Hide
-
Cystic fibrosis transmembrane conductance regulator modulator administration to a F508del heterozygous infant with meconium pseudocyst and short bowel syndrome: A case report.
Pediatric pulmonology 2023 Stoffella S, Ly N, McGarry M, Neemuchwala F, Church G, Chan M, Cuneo A, Omori M, Gibb E -
Ethnic differences in staphylococcus aureus acquisition in cystic fibrosis.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2023 McGarry ME, Huang CY, Ly NP -
DYNAMIC RISK PREDICTION TRIGGERED BY INTERMEDIATE EVENTS USING SURVIVAL TREE ENSEMBLES.
The annals of applied statistics 2023 Sun Y, Chiou SH, Wu CO, McGarry M, Huang CY -
How many billions is enough? Prioritizing profits over patients with cystic fibrosis.
Pediatric pulmonology 2023 McGarry ME, Gibb ER, Laguna TA, O'Sullivan BP, Sawicki GS, Zobell JT -
Changes in the Use of Invasive and Noninvasive Mechanical Ventilation in Pediatric Asthma: 2009-2019.
Annals of the American Thoracic Society 2023 Smith MA, Dinh D, Ly NP, Ward SL, McGarry ME, Zinter MS -
Detection of disease-causing CFTR variants in state newborn screening programs.
Pediatric pulmonology 2022 McGarry ME, Ren CL, Wu R, Farrell PM, McColley SA -
In response to "who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies".
Respiratory medicine 2022 McGarry ME, McColley SA, Taylor-Cousar J -
Food insecurity and mental health during the COVID-19 pandemic in cystic fibrosis households.
Pediatric pulmonology 2022 Lim JT, Ly NP, Willen SM, Iwanaga K, Gibb ER, Chan M, Church GD, Neemuchwala F, McGarry ME -
Left behind: The potential impact of CFTR modulators on racial and ethnic disparities in cystic fibrosis.
Paediatric respiratory reviews 2021 McGarry ME, Gibb ER, Oates GR, Schechter MS -
Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2020 McGarry ME, Huang CY, Nielson DW, Ly NP -
Outcomes of Children With Cystic Fibrosis Admitted to PICUs.
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2020 Smith MA, McGarry ME, Ly NP, Zinter MS -
Transparency and diversity in cystic fibrosis research.
Lancet (London, England) 2020 McGarry M -
Triple Therapy for Cystic Fibrosis with a Phe508del CFTR Mutation.
The New England journal of medicine 2020 McGarry ME -
The demographics of adverse outcomes in cystic fibrosis.
Pediatric pulmonology 2019 McGarry ME, Williams WA, McColley SA -
Identification of CFTR variants in Latino patients with cystic fibrosis from the Dominican Republic and Puerto Rico.
Pediatric pulmonology 2019 Zeiger AM, McGarry ME, Mak ACY, Medina V, Salazar S, Eng C, Liu AK, Oh SS, Nuckton TJ, Jain D, Blackwell TW, Kang HM, Abecasis G, Oñate LC, Seibold MA, Burchard EG, Rodriguez-Santana J -
Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States.
Pediatric pulmonology 2019 McGarry ME, Neuhaus JM, Nielson DW, Ly NP -
Pulmonary Metagenomic Sequencing Suggests Missed Infections in Immunocompromised Children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019 Zinter MS, Dvorak CC, Mayday MY, Iwanaga K, Ly NP, McGarry ME, Church GD, Faricy LE, Rowan CM, Hume JR, Steiner ME, Crawford ED, Langelier C, Kalantar K, Chow ED, Miller S, Shimano K, Melton A, Yanik … -
A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma.
The pharmacogenomics journal 2018 Spear ML, Hu D, Pino-Yanes M, Huntsman S, Eng C, Levin AM, Ortega VE, White MJ, McGarry ME, Thakur N, Galanter J, Mak ACY, Oh SS, Ampleford E, Peters SP, Davis A, Kumar R, Farber HJ, Meade K, Avila PC… -
An admixture mapping meta-analysis implicates genetic variation at 18q21 with asthma susceptibility in Latinos.
The Journal of allergy and clinical immunology 2018 Gignoux CR, Torgerson DG, Pino-Yanes M, Uricchio LH, Galanter J, Roth LA, Eng C, Hu D, Nguyen EA, Huntsman S, Mathias RA, Kumar R, Rodriguez-Santana J, Thakur N, Oh SS, McGarry M, Moreno-Estrada A, … -
Breastfeeding associated with higher lung function in African American youths with asthma.
The Journal of asthma : official journal of the Association for the Care of Asthma 2016 Oh SS, Du R, Zeiger AM, McGarry ME, Hu D, Thakur N, Pino-Yanes M, Galanter JM, Eng C, Nishimura KK, Huntsman S, Farber HJ, Meade K, Avila P, Serebrisky D, Bibbins-Domingo K, Lenoir MA, Ford JG, … -
Minorities Are Underrepresented in Clinical Trials of Pharmaceutical Agents for Cystic Fibrosis.
Annals of the American Thoracic Society 2016 McGarry ME, McColley SA -
Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma.
Chest 2015 McGarry ME, Castellanos E, Thakur N, Oh SS, Eng C, Davis A, Meade K, LeNoir MA, Avila PC, Farber HJ, Serebrisky D, Brigino-Buenaventura E, Rodriguez-Cintron W, Kumar R, Bibbins-Domingo K, Thyne SM, … -
The lung corps' approach to reducing health disparities in respiratory disease.
Annals of the American Thoracic Society 2014 Thakur N, McGarry ME, Oh SS, Galanter JM, Finn PW, Burchard EG, ATS Health Equality Committee -
Normalization of sweat chloride concentration and clinical improvement with ivacaftor in a patient with cystic fibrosis with mutation S549N.
Chest 2013 McGarry ME, Nielson DW